INC.; ANIMAL HEALTH DIVISION;ARTHRODYNAMIC TECHNOLOGIES
发明人:
FRANK D. MARCUM,JOHN WILLIAM SEANOR,FOSTER HAROLD NORTHROP
申请号：
BRPI0812725
公开号：
BRPI0812725A2
申请日:
2008.06.20
申请国别(地区):
BR
年份:
2014
代理人:
摘要：
The present invention provides a composition, and a method of use thereof for treating connective tissue damage in man and in animals, which comprises a therapeutically effective amount of chondroitin sulfate, N-acetyl D-glucosamine, and hyaluronan (hyaluronic acid). Particularly, the present invention provides a composition, and a method of use thereof, for treating connective tissue damage including, but not limited to, arthritic disease, osteoarthritis, rheumatoid arthritis, osterochondrosis dessicans, cartilage damage, joint injury, joint inflammation, joint synovitis, degenerative joint disease (DJD), post surgical DJD, traumatic injury, fracture, tendon damage, ligament damage, skeletal damage, musculoskeletal damage, fiber damage, adipose tissue damage, blood cell damage, and plasma damage. Compositions for delivery of the present invention include those for parenteral, oral, and transmucosal delivery and for direct surgical placement onto the affected tissues.
